Does OSIMERTINIB Cause Full blood count decreased? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Full blood count decreased have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
19
Reports of Full blood count decreased with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
1
Deaths
10
Hospitalizations
How Dangerous Is Full blood count decreased From OSIMERTINIB?
Of the 19 reports, 1 (5.3%) resulted in death, 10 (52.6%) required hospitalization.
Is Full blood count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Full blood count decreased?
LENALIDOMIDE (6,059)
PALBOCICLIB (1,964)
POMALIDOMIDE (1,599)
RUXOLITINIB (469)
VENETOCLAX (424)
NIRAPARIB (356)
REVLIMID (352)
ADALIMUMAB (212)
IXAZOMIB (196)
DEXAMETHASONE (184)
Which OSIMERTINIB Alternatives Have Lower Full blood count decreased Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN